Thanks to visit codestin.com
Credit goes to www.scribd.com

0% found this document useful (0 votes)
149 views3 pages

Spirometry OSCE

Spirometry is a pulmonary function test used to diagnose and monitor lung diseases. It measures how much air a person can inhale and exhale. The document outlines the indications, contraindications, preparation, technique, and parameters measured during spirometry testing. It also describes normal lung volumes and the appearance of obstructive and restrictive lung diseases on spirometry tests.

Uploaded by

Golam Sarwar
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
149 views3 pages

Spirometry OSCE

Spirometry is a pulmonary function test used to diagnose and monitor lung diseases. It measures how much air a person can inhale and exhale. The document outlines the indications, contraindications, preparation, technique, and parameters measured during spirometry testing. It also describes normal lung volumes and the appearance of obstructive and restrictive lung diseases on spirometry tests.

Uploaded by

Golam Sarwar
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 3

Spirometry

Indications
 Assisting with diagnostic evaluations
 Monitoring of pulmonary function
 Evaluating disability or impairment
 Providing public health information

Contraindications
 Unstable cardiovascular status, unstable angina, recent MI <1/12, PE
 Haemoptysis of unknown origin
 Recent PTX
 Thoracic abdominal or cerebral aneurysms
 Recent thoracic, abdominal or eye surgery
 Acute disorders such as nausea or vomiting
 Severe respiratory distress
 Physical limitations
 Cognitive impairment, dementia

Preparation
 Carry out infection control measures – hand washing
 Document if the patient has withheld bronchodilator
 Ceased smoking > 1 hour prior, no alcohol > 4 hours prior, no vigorous exercise > 30 mins prior, no
large meal > 2 hours prior
 Measure height and weight

Technique
 Perform FVC and FEV1 manoeuvre – repeat x 3
o Correct use of mouthpiece and nose clip
o Correct posture with head slightly elevated
o Position of mouthpiece, including tight mouth seal over the mouthpiece
o Complete inhalation prior to FVC and FEV1
o Rapid and complete exhalation with maximal force
 If flow-volume loop is being preformed (to measure forced inspiratory vital capacity)
o The patient will exhale rapidly and forcefully until end of test criteria are achieved aadn then
inhale as rapidly as possible back to TLC
 Performing the VC testing
o Slow, complete and relatively constant flow inhalation for VC
o Slow, complete and relatively constant flow exhalation for VC
o Emphasis on complete filling and emptying of the lungs

Post bronchodilatory therapy


 4 puffs (4 x 100mcg) salbutamol via spacer, perform 15 mins post
 An increase in FEV1 and/or FVC of ≥ 12% compared with pre-bronchodilator spirometer and ≥200ml
increase in FEV1 and FVC compared with a pre-bronchodilator spirometry
= Tweet
Lung volumes

FLOW VOLUME LOOP

PARAMETERS
• VC = 70mL/kg
= IRV + TV + ERV
• IRV = 45mL/kg
• TV = 10mL/kg – volume breathed in & out during a normal
breath (without extra effort)
• ERV = 15mL/kg – extra volume beyond normal expiration
• RV = 15mL\kg (not measured by spirometer)
• TLC = 85L\kg
• FRC = 30mL\kg
• FEV1 = forced expiratory volume in 1 second (normally 4L)
• FVC = forced vital capacity (a little lower than VC because of
dynamic airway closure; normally ~5L)
• PEFR = peak flow rate over an expiration (normally 500L/min)
• FEV1/FVC (normal = 80%)
Obstructive disease = FEV1 reduced more than FVC, low
FEV1/FVC
Restrictive disease = FEV1 & FVC reduced but FEV1/FVC normal or increased

After a relatively small amount of gas has been exhaled -> flow is limited by airway compression
determined by (1) elastic recoil force of lung & (2) resistance of airways upstream of the collapse
point.

• FEF50%
• FIF50%
• FEF/FIF50 = if > 1 -> inspiratory flow is affected more than expiratory -> extrathoracic site of obstruction
OBSTRUCTIVE DISEASE
 flow rate very low in relation to lung volume (c/o resistance to flow – scooped out appearance often
seen following the point of maximum flow)
 total lung capacity is large, but expiration ends prematurely c/o early airway closure from increased
smooth muscle tone of bronchi (asthma) or loss of radial traction from surrounding parenchyma
(emphysema).
 equal pressure point is close to the alveolus and the transmural pressure gradient can become
negative quickly -> collapse.
 encroachment of VC by an increased RV caused by hyperinflation (‘air trapping’)

Severity Features Respiratory funciton


Mild Exertional symptoms FEV1 and PEFR >60% predicted
Able to speak normally
Good response to usual therapy
Moderate Dyspnoeic at rest FEV1 and PEFR 40 – 60% predicted
Able to speak in short sentences PEFR 200 – 300L/min
Chest tightness
Wheeze
Partial or short-term relief with usual therapy
Nocturnal symptoms
Severe Laboured respiration FEV1 and PEFR unable or <40% predicted
Sweating, restless SPO2 <90% on RA
Tachycardia, HR >120bpm PEFR <200L/min
Tachypnoea, RR >25/minute
Difficulty speaking – words or short sentences
Near death Exhaustion FEV1 and PEFR in appropriate
Confusion, coma SPO2 <90% despite supplemental O2
Cyanosis
Sweating
Silent chest
Inabilty to speak
Reduced respiratory effort
Dysrhythmia, bradycardia
Hypotension

RESTRICTIVE DISEASE
 total volume exhaled and flow rate reduced
 inspiration limited by reduced compliance of lung/chest wall or weakness of inspiratory muscles

You might also like